Immunotherapy for Infectious Diseases

Dendritic Cells 115
dendritic cells into CD8alpha-positive dendritic cells in vivo. Blood. 96(5):1865–1872.
105. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise
from a common bone marrow progenitor cell subset. Immunity 1995; 3:459–473.
106. Olweus J, BitMansour A, Warnke R, et al. Dendritic cell ontogeny: a human dendritic cell
lineage of myeloid origin. Proc Natl Acad Sci USA 1997; 94:12551–12556.
107. Markowicz S, Engleman EG. Granulocyte-macrophage colony-stimulating factor promotes
differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin
Invest 1990; 85:955–961.
108. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using
autologous antigen-pulsed dendritic cells. Nat Med 1996; 2:52–58.
109. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha
cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360:258–261.
110. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human
blood. J Exp Med 1994; 180:83–93.
111. Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA. Generation of
immunostimulatory dendritic cells from human CD34� hematopoietic progenitor cells of
the bone marrow and peripheral blood. Cancer Res 1995; 55:1099–1104.
112. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human
dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus
interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;
179:1109–1118.
113. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. Therapy of murine tumors with tumor
peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation and T helper cell
1-associated cytokines. J Exp Med 1996; 183:87–97.
114. Paglia P, Chiodani C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro
with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp
Med 1996; 183:317–322.
115. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or
tumor lysate-pulsed dendritic cells. Nat Med 1998; 4:328–332.
116. Lotze MT, Hellerstedt B, Stolinski L, et al. The role of interleukin-2, interleukin-12 and
dendritic cells in cancer therapy. Cancer J Sci Am 1997; 3:S109.
117. Rosenzwajg M, Canque B, Gluckman JC. Human dendritic cell differentiation pathway
from CD34� hematopoietic precursor cells. Blood 1996; 87:535–544.
118. Maraskovsky E, Brasel K, Teepe M, et al. Dramatic increase in the numbers of functionally
mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations
identified. J Exp Med 1996; 184:1953–1962.
119. Fong L, Hou Y, Rivas A, et al. (2001). Altered peptide ligand vaccination with Flt3 ligand
expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci USA. 98(15):
8809–8814.
120. Alters SE, Gadea JR, Sorich M, O’Donoghue G, Talib S, Philip R. Dendritic cells pulsed
with CEA peptide induce CEA-specific CTL with restricted TCR repertoire. J Immunother
1998; 21:17–26.
121. Dietz AB, Vuk-Pavlovic S. High efficiency adenovirus-mediated gene transfer to human
dendritic cells. Blood 1998; 91:392–398.
122. Kim CJ, Cormier J, Roden M, et al. Use of recombinant poxviruses to stimulate antimelanoma
T cell reactivity. Ann Surg Oncol 1998; 5:64–76.
123. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12:991.
124. Paglia P, Medina E, Arioli I, Guzman CA, Colombo MP. Gene transfer in dendritic cells
induced by oral DNA vaccination with Salmonella typhimurium, results in protective
immunity against a murine fibrosarcoma. Blood 1998; 92:3172–3176.
125. Pan ZK, Ikonomidis G, Lazenby A, Pardoll D, Paterson Y. A recombinant Listeria monocytogenes
vaccine expressing a model tumor antigen protects mice against lethal tumor